<DOC>
	<DOCNO>NCT00436124</DOCNO>
	<brief_summary>This study evaluate efficacy safety Tamiflu patient clinically-diagnosed influenza occur influenza outbreak within community . Patients randomize receive Tamiflu 75mg bid orally plus support therapy ( NSAIDs antibiotic ) support therapy alone . The anticipated time study treatment &lt; 3 month , target sample size &lt; 100 individual .</brief_summary>
	<brief_title>A Study Tamiflu ( Oseltamivir ) Treatment Laboratory-Confirmed Influenza .</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Oseltamivir</mesh_term>
	<criteria>adult patient , 1864 year age ; ambulatory ; influenzalike illness ; positive rapid assay detection influenza antigen . presentation &gt; 36h onset symptom ; influenzalike symptom outside outbreak base local surveillance activity ; influenza vaccination November 2006 January 2007 ; receipt antiviral therapy , systemic steroid immunosuppressant within 2 week prior study day 1 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>